Refine
Year of publication
Document Type
- Article (69)
Language
- English (69) (remove)
Has Fulltext
- yes (69)
Is part of the Bibliography
- no (69)
Keywords
- - (31)
- periodontitis (8)
- Alzheimer’s disease (4)
- magnetic resonance imaging (4)
- obesity (4)
- Obesity (3)
- cohort study (3)
- epidemiology (3)
- metabolomics (3)
- Brain-derived neurotrophic factor (2)
- Depression (2)
- Epidemiology (2)
- Iodine (2)
- Thyroid (2)
- Thyroid-stimulating hormone (2)
- Vitamin D (2)
- biomarkers (2)
- cardiorespiratory fitness (2)
- caries (2)
- depression (2)
- metabolic syndrome (2)
- periodontal treatment (2)
- tooth loss (2)
- 3,5-Diiodothyronine (1)
- APOE ε4 (1)
- Abdominal fat (1)
- Aging (1)
- Albuminuria (1)
- Alexithymia (1)
- Alzheimer's disease (1)
- Ankle-brachial index (1)
- BDNF (1)
- Body fat (1)
- Brain health (1)
- CVD biomarker (1)
- Centrality (1)
- Childhood abuse (1)
- Connectivity (1)
- Correlation networks (1)
- Cortex (1)
- Cortical thickness (1)
- Cortisol (1)
- Depressive symptoms (1)
- ECG (1)
- Estimated glomerular filtration rate (1)
- FreeSurfer (1)
- GWA (1)
- General population (1)
- Glucocorticoid receptor (1)
- HLA (1)
- Hand grip strength (1)
- Hippocampus (1)
- Individualization (1)
- Iodine status (1)
- Kidney disease (1)
- Left ventricular geometry and function (1)
- Left ventricular hypertrophy (1)
- Left ventricular mass (1)
- Leptin (1)
- MDD (1)
- MHC (1)
- MRI (1)
- MRI-proton-density-fat-fraction (PDFF) (1)
- Mastication (1)
- Measurement error (1)
- NAFLD (1)
- NAKO (1)
- NMR metabolomics (1)
- NMR spectroscopy (1)
- NR3C1 (1)
- Outcomes research (1)
- PHQ-9 (1)
- Peripheral arterial disease (1)
- Population-based study (1)
- Prediction (1)
- Prevention (1)
- RMSSD (1)
- Resilience (1)
- Risk factors (1)
- Sleep (1)
- Slow wave sleep (1)
- Spermidine (1)
- Sphingosine-1-phosphate (1)
- Staphyloccus aureus (1)
- Study of Health in Pomerania (1)
- TSH (1)
- TSST-1 (1)
- Teeth (1)
- The Study of Health in Pomerania (1)
- Thyroglobulin (1)
- Thyroid function (1)
- Thyroid hormone (1)
- Thyroid imaging (1)
- Thyrotropin (1)
- Tooth loss (1)
- Total testosterone (1)
- Trigonelline (1)
- Urinary iodine excretion (1)
- Urine metabolome (1)
- Variability (1)
- Verbal memory (1)
- Visceral adipose tissue (1)
- Visceral body fat (1)
- abuse (1)
- adult-onset (1)
- affective disorders (1)
- alpha diversity (1)
- amyloid beta (1)
- anthropometry (1)
- anti- (1)
- antibody (1)
- antibody repertoire (1)
- apparently healthy (1)
- area deprivation (1)
- autoimmune (1)
- bacteria (1)
- baseline imbalance (1)
- benzoate metabolism (1)
- biological aging (1)
- biomarker (1)
- bipolar disorder (1)
- blood cell metabolism (1)
- blood count (1)
- body mass index (1)
- body weights and measures (1)
- bone quality (1)
- bone remodelling (1)
- bone turnover marker (1)
- cardiometabolic diseases (1)
- cardiorespiratory exercise capacity (1)
- cardiovascular diseas (1)
- citrulline (1)
- clinical attachment level (1)
- cluster (1)
- cognition (1)
- cohorts (1)
- complete blood count (1)
- continuous outcome (1)
- cortical thickness (1)
- cortisol (1)
- delivery mode (1)
- dementia (1)
- dental flossing (1)
- depresion (1)
- diabetes mellitus (1)
- diagnostic techniques and procedures (1)
- diet (1)
- directed acyclic graphs (1)
- echocardiography (1)
- edentulism (1)
- education (1)
- endothelium (1)
- epidemiologic studies (1)
- estimated bone mineral density (1)
- fT3 (1)
- fT4 (1)
- fat-free mass (1)
- flow‐mediated dilation (1)
- general population-based cohort (1)
- glucose homeostasis (1)
- glucose metabolism (1)
- heart rate variability (HRV) (1)
- hepatic steatosis (1)
- hippocampal volume (1)
- homoarginine (1)
- host-pathogen-interaction (1)
- immunoproteomics (1)
- income (1)
- individual participant data (1)
- individualized medicine (1)
- inflammation (1)
- inter-dental cleaning (1)
- interdental brushing (1)
- iron surrogates (1)
- large cohort data (1)
- late-onset (1)
- lipid profile (1)
- lipoprotein profile (1)
- lipoprotein profiling (1)
- liver fat content (1)
- longitudinal cohort study (1)
- machine learning (1)
- macrovascular disease (1)
- measurement error (1)
- mediatation (1)
- mediation (1)
- memory (1)
- metabolic phenotypes (1)
- metabolism (1)
- metabolome (1)
- metabotypes (1)
- miRNA (1)
- microbiome (1)
- neglect (1)
- nitric oxide (1)
- non-randomized studies (1)
- number of missing teeth (1)
- offspring (1)
- oral contraceptives (1)
- orofacial pain (1)
- peak oxygen uptake (1)
- perinatal (1)
- periodontal diseases (1)
- personalized medicine (1)
- phenotyping (1)
- population-based (1)
- population-based imaging (1)
- population-based studies (1)
- population‐based study (1)
- powered tooth brush (1)
- powered toothbrush (1)
- pre-symptomatic Alzheimer’s disease marker (1)
- prediabetes (1)
- prediction modelling (1)
- probing depth (1)
- prognostic factors (1)
- prospective cohort study (1)
- proton pump inhibitor (1)
- public health (1)
- radiomics (1)
- registry-based analysis (1)
- risk factor progression (1)
- risk factors (1)
- rs56149945 (1)
- sedentarism (1)
- self-report (1)
- serum markers (1)
- sex (1)
- sex differences (1)
- sex-specific (1)
- signal transduction (1)
- sleep disorders (1)
- sleep macro-architecture (1)
- slow-wave sleep (1)
- spermidine (1)
- spleen volume (1)
- superantigen (1)
- third molar (1)
- thyroid (1)
- tooth extraction (1)
- toxic shock syndrome (1)
- trace amine-associated receptor 1 (1)
- trauma (1)
- variants (1)
- weight regulation (1)
- white matter hyperintensities (1)
- whole-body magnetic resonance imaging (1)
- whole‐body imaging (1)
Institute
- Institut für Community Medicine (18)
- Klinik für Psychiatrie und Psychotherapie (13)
- Kliniken und Polikliniken für Innere Medizin (13)
- Institut für Klinische Chemie und Laboratoriumsmedizin (7)
- Zentrum für Zahn-, Mund- und Kieferheilkunde (7)
- Institut für Biometrie und Medizinische Informatik (2)
- Institut für Diagnostische Radiologie (2)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (2)
- Klinik und Poliklinik für Augenheilkunde (2)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (2)
Publisher
- Wiley (15)
- S. Karger AG (10)
- Frontiers Media S.A. (9)
- MDPI (9)
- Nature Publishing Group (6)
- Springer Nature (5)
- Public Library of Science (PLoS) (4)
- SAGE Publications (4)
- BMJ Publishing Group (1)
- BioMed Central (BMC) (1)
Variability of Thyroid Measurements from Ultrasound and Laboratory in a Repeated Measurements Study
(2020)
Background: Variability of measurements in medical research can be due to different sources. Quantification of measurement errors facilitates probabilistic sensitivity analyses in future research to minimize potential bias in epidemiological studies. We aimed to investigate the variation of thyroid-related outcomes derived from ultrasound (US) and laboratory analyses in a repeated measurements study. Subjects and Methods: Twenty-five volunteers (13 females, 12 males) aged 22–70 years were examined once a month over 1 year. US measurements included thyroid volume, goiter, and thyroid nodules. Laboratory measurements included urinary iodine concentrations and serum levels of thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), and thyroglobulin. Variations in continuous thyroid markers were assessed as coefficient of variation (CV) defined as mean of the individual CVs with bootstrapped confidence intervals and as intraclass correlation coefficients (ICCs). Variations in dichotomous thyroid markers were assessed by Cohen’s kappa. Results: CV was highest for urinary iodine concentrations (56.9%), followed by TSH (27.2%), thyroglobulin (18.2%), thyroid volume (10.5%), fT3 (8.1%), and fT4 (6.3%). The ICC was lowest for urinary iodine concentrations (0.42), followed by fT3 (0.55), TSH (0.64), fT4 (0.72), thyroid volume (0.87), and thyroglobulin (0.90). Cohen’s kappa values for the presence of goiter or thyroid nodules were 0.64 and 0.70, respectively. Conclusion: Our study provides measures of variation for thyroid outcomes, which can be used for probabilistic sensitivity analyses of epidemiological data. The low intraindividual variation of serum thyroglobulin in comparison to urinary iodine concentrations emphasizes the potential of thyroglobulin as marker for the iodine status of populations.
Context: 3,5-Diiodo-<smlcap>L</smlcap>-thyronine (3,5-T<sub>2</sub>) is a thyroid hormone metabolite which exhibited versatile effects in rodent models, including the prevention of insulin resistance or hepatic steatosis typically forced by a high-fat diet. With respect to euthyroid humans, we recently observed a putative link between serum 3,5-T<sub>2</sub> and glucose but not lipid metabolism. Objective: The aim of the present study was to widely screen the urine metabolome for associations with serum 3,5-T<sub>2</sub> concentrations in healthy individuals. Study Design and Methods: Urine metabolites of 715 euthyroid participants of the population-based Study of Health in Pomerania (SHIP-TREND) were analyzed by <sup>1</sup>H-NMR spectroscopy. Multinomial logistic and multivariate linear regression models were used to detect associations between urine metabolites and serum 3,5-T<sub>2</sub> concentrations. Results: Serum 3,5-T<sub>2</sub> concentrations were positively associated with urinary levels of trigonelline, pyroglutamate, acetone and hippurate. In detail, the odds for intermediate or suppressed serum 3,5-T<sub>2</sub> concentrations doubled owing to a 1-standard deviation (SD) decrease in urine trigonelline levels, or increased by 29-50% in relation to a 1-SD decrease in urine pyroglutamate, acetone and hippurate levels. Conclusion: Our findings in humans confirmed the metabolic effects of circulating 3,5-T<sub>2</sub> on glucose and lipid metabolism, oxidative stress and enhanced drug metabolism as postulated before based on interventional pharmacological studies in rodents. Of note, 3,5-T<sub>2</sub> exhibited a unique urinary metabolic profile distinct from previously published results for the classical thyroid hormones.
Life-threatening toxic shock syndrome is often caused by the superantigen toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus. A well-known risk factor is the lack of neutralizing antibodies. To identify determinants of the anti-TSST-1 antibody response, we examined 976 participants of the German population-based epidemiological Study of Health in Pomerania (SHIP-TREND-0). We measured anti-TSST-1 antibody levels, analyzed the colonization with TSST-1-encoding S. aureus strains, and performed a genome-wide association analysis of genetic risk factors. TSST-1-specific serum IgG levels varied over a range of 4.2 logs and were elevated by a factor of 12.3 upon nasal colonization with TSST-1-encoding S. aureus. Moreover, the anti-TSST-1 antibody levels were strongly associated with HLA class II gene loci. HLA-DRB1*03:01 and HLA-DQB1*02:01 were positively, and HLA-DRB1*01:01 as well as HLA-DQB1*05:01 negatively associated with the anti-TSST-1 antibody levels. Thus, both toxin exposure and HLA alleles affect the human antibody response to TSST-1.
Aim
According to retrospective clinical studies, periodontal treatment retains teeth. However, evidence on the effectivity of periodontal treatment stemming from the general population is lacking.
Materials and Methods
We analysed data of periodontally treated patients from routine data of a major German national health insurance (BARMER-MV; sub-sample of the Federal State of Mecklenburg-Vorpommern) and from a clinical cohort (Greifswald Approach to Individualized Medicine, GANI_MED), as well as periodontally untreated and treated participants of the Study of Health in Pomerania (SHIP-TREND) with either ≥2 or ≥4 teeth with pocket depths ≥4 mm. Yearly tooth loss (YTL) estimates and incidence rates were evaluated.
Results
For moderately to severely affected groups, YTL and incidence rates were higher in BARMER-MV patients (0.35 and 0.18, respectively) than in untreated SHIP-TREND controls (0.19 and 0.08, respectively). In line, treated SHIP-TREND participants exhibited higher YTL rates than untreated SHIP-TREND controls (0.26 vs. 0.19). For severely affected groups, results with respect to tooth loss were inconclusive regarding the beneficial effects of periodontal treatment conducted either in the university (GANI_MED data) or in the general practice.
Conclusion
Until 2021, periodontal treatment performed in German general dental practices within the national health insurance system was probably not efficient in retaining more teeth in the short- to mid-term. Since reimbursement schemes were changed in 2021 and now cover periodontal treatment to a much larger extent, the future will show whether these new reimbursement codes will improve the quality of periodontal treatment and whether they will lead to more long-term tooth retainment.
Periodontitis is one of the most prevalent oral diseases worldwide and is caused by multifactorial interactions between host and oral bacteria. Altered cellular metabolism of host and microbes releases a number of intermediary end products known as metabolites. There is an increasing interest in identifying metabolites from oral fluids such as saliva to widen the understanding of the complex pathogenesis of periodontitis. It is believed that some metabolites might serve as indicators toward early detection and screening of periodontitis and perhaps even for monitoring its prognosis in the future. Because contemporary periodontal screening methods are deficient, there is an urgent need for novel approaches in periodontal screening procedures. To this end, we associated oral parameters (clinical attachment level, periodontal probing depth, supragingival plaque, supragingival calculus, number of missing teeth, and removable denture) with a large set of salivary metabolites (n = 284) obtained by mass spectrometry among a subsample (n = 909) of nondiabetic participants from the Study of Health in Pomerania (SHIP-Trend-0). Linear regression analyses were performed in age-stratified groups and adjusted for potential confounders. A multifaceted image of associated metabolites (n = 107) was revealed with considerable differences according to age groups. In the young (20 to 39 y) and middle-aged (40 to 59 y) groups, metabolites were predominantly associated with periodontal variables, whereas among the older subjects (≥60 y), tooth loss was strongly associated with metabolite levels. Metabolites associated with periodontal variables were clearly linked to tissue destruction, host defense mechanisms, and bacterial metabolism. Across all age groups, the bacterial metabolite phenylacetate was significantly associated with periodontal variables. Our results revealed alterations of the salivary metabolome in association with age and oral health status. Among our comprehensive panel of metabolites, periodontitis was significantly associated with the bacterial metabolite phenylacetate, a promising substance for further biomarker research.
Homoarginine (hArg) is a non-essential cationic amino acid which inhibits hepatic alkaline phosphatases to exert inhibitory effects on bile secretion by targeting intrahepatic biliary epithelium. We analyzed (1) the relationship between hArg and liver biomarkers in two large population-based studies and (2) the impact of hArg supplementation on liver biomarkers. We assessed the relationship between alanine transaminase (ALT), aspartate aminotransferase (AST), γ-glutamyltransferase (GGT), alkaline phosphatases (AP), albumin, total bilirubin, cholinesterase, Quick’s value, liver fat, and Model for End-stage Liver Disease (MELD) and hArg in appropriately adjusted linear regression models. We analyzed the effect of L-hArg supplemention (125 mg L-hArg daily for 4 weeks) on these liver biomarkers. We included 7638 individuals (men: 3705; premenopausal women: 1866, postmenopausal women: 2067). We found positive associations for hArg and ALT (β 0.38 µkatal/L 95% confidence interval (CI): 0.29; 0.48), AST (β 0.29 µkatal/L 95% CI 0.17; 0.41), GGT (β 0.033 µkatal/L 95% CI 0.014; 0.053), Fib-4 score (β 0.08 95% CI 0.03; 0.13), liver fat content (β 0.016% 95% CI 0.006; 0.026), albumin (β 0.030 g/L 95% CI 0.019; 0.040), and cholinesterase (β 0.003 µkatal/L 95% CI 0.002; 0.004) in males. In premenopausal women hArg was positively related with liver fat content (β 0.047% 95%CI 0.013; 0.080) and inversely with albumin (β − 0.057 g/L 95% CI − 0.073; − 0.041). In postmenopausal women hARG was positively associated with AST (β 0.26 µkatal/L 95% CI 0.11; 0.42). hArg supplementation did not affect liver biomarkers. We summarize that hArg may be a marker of liver dysfunction and should be explored further.
The relationship between Alzheimer's-related brain atrophy patterns and sleep macro-architecture
(2022)
Introduction
Sleep is increasingly recognized as a major risk factor for neurodegenerative disorders such as Alzheimer's disease (AD).
Methods
Using an magnetic resonance imaging (MRI)–based AD score based on clinical data from the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI1) case-control cohort, we investigated the associations between polysomnography-based sleep macro-architecture and AD-related brain atrophy patterns in 712 pre-symptomatic, healthy subjects from the population-based Study of Health in Pomerania.
Results
We identified a robust inverse association between slow-wave sleep and the AD marker (estimate: −0.019; 95% confidence interval: −0.03 to −0.0076; false discovery rate [FDR] = 0.0041), as well as with gray matter (GM) thicknesses in typical individual cortical AD-signature regions. No effects were identified regarding rapid eye movement or non–rapid eye movement (NREM) stage 2 sleep, and NREM stage 1 was positively associated with GM thickness, mainly in the prefrontal cortical regions.
Discussion
There is a cross-sectional relationship between AD-related neurodegenerative patterns and the proportion of sleep spent in slow-wave sleep.
The hypothalamus–pituitary–adrenal axis is the main physiological stress response system and regulating the release of cortisol. The two corticoid receptors encoded by the genes NR3C1 and NR3C2 are the main players in regulating the physiological response to cortisol. This biological system has been linked to neurocognitive processes and memory, yet the mechanisms remain largely unclear. In two independent general population studies (SHIP, total sample size > 5500), we aim to diseantangle the effects of genetic variation, gene expression and cortisol on verbal memory and memory associated brain volume. Especially for NR3C1 results exhibited a consistent pattern of direct an interactive effects. All three biological layers, genetic variation (rs56149945), gene expression for NR3C1 and cortisol levels, were directly associated with verbal memory. Interactions between these components showed significant effects on verbal memory as well as hippocampal volume. For NR3C2 such a complex association pattern could not be observed. Our analyses revealed that different components of the stress response system are acting together on different aspects of cognition. Complex phenotypes, such as cognition and memory function are regulated by a complex interplay between different genetic and epigenetic features. We promote the glucocorticoid receptor NR3C1 as a main target to focus in the context of verbal memory and provided a mechanistic concept of the interaction between various biological layers spanning NR3C1 function and its effects on memory. Especially the NR3C1 transcript seemed to be a key element in this complex system.
For the goal of individualized medicine, it is critical to have clinical phenotypes at hand which represent the individual pathophysiology. However, for most of the utilized phenotypes, two individuals with the same phenotype assignment may differ strongly in their underlying biological traits. In this paper, we propose a definition for individualization and a corresponding statistical operationalization, delivering thereby a statistical framework in which the usefulness of a variable in the meaningful differentiation of individuals with the same phenotype can be assessed. Based on this framework, we develop a statistical workflow to derive individualized phenotypes, demonstrating that under specific statistical constraints the prediction error of prediction scores contains information about hidden biological traits not represented in the modeled phenotype of interest, allowing thereby internal differentiation of individuals with the same assigned phenotypic manifestation. We applied our procedure to data of the population-based Study of Health in Pomerania to construct a refined definition of obesity, demonstrating the utility of the definition in prospective survival analyses. Summarizing, we propose a framework for the individualization of phenotypes aiding personalized medicine by shifting the focus in the assessment of prediction models from the model fit to the informational content of the prediction error.